{"@id":"https://bioecon.ru/technology/inhaled-nasal-delivery-platforms/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/inhaled-nasal-delivery-platforms/","json":"https://en.bioecon.ru/api/v1/technology/inhaled-nasal-delivery-platforms/index.json"},"id":"inhaled-nasal-delivery-platforms","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/allozymes/","https://bioecon.ru/companies/tsingke-biotechnology/","https://bioecon.ru/companies/daicel/","https://bioecon.ru/companies/dyadic-international/","https://bioecon.ru/companies/string-bio/","https://bioecon.ru/companies/syncozymes/","https://bioecon.ru/companies/giant-biogene-holding/"]},"maturity":8,"name":"Inhaled and Nasal Mucosal Delivery Platforms","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Engineered low-density carrier particles"},{"n":2,"title":"Nose-to-brain mucosal permeation"},{"n":3,"title":"Fine particle fraction optimization"},{"n":4,"title":"Direct alveolar antifibrotic targeting"}],"summary":"Formulation and device platforms engineering engineered dry powders and nasal sprays for high alveolar deposition in idiopathic pulmonary fibrosis (IPF) and direct nose-to-brain targeting.","url":"/technology/inhaled-nasal-delivery-platforms/","verified":"2026-11-22"}